229 related articles for article (PubMed ID: 30611622)
1. Low expression of PDHA1 predicts poor prognosis in gastric cancer.
Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y
Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622
[TBL] [Abstract][Full Text] [Related]
2. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
3. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
Ma G; Dai W; Sang A; Yang X; Gao C
Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
[TBL] [Abstract][Full Text] [Related]
8. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
10. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
11. Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
Kong Y; Zheng Y; Jia Y; Li P; Wang Y
Oncol Rep; 2016 Oct; 36(4):1852-60. PubMed ID: 27498782
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
Ren J; Xu S; Guo D; Zhang J; Liu S
Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
14. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of BCAT1 is a prognostic marker in gastric cancer.
Xu Y; Yu W; Yang T; Zhang M; Liang C; Cai X; Shao Q
Hum Pathol; 2018 May; 75():41-46. PubMed ID: 29447920
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the ATM gene linked to poor prognosis for gastric cancer of different nationalities in Xinjiang.
Han M; Ma L; Qu Y; Tang Y
Pathol Res Pract; 2017 Aug; 213(8):908-914. PubMed ID: 28647209
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical implication of S100A12 in gastric carcinoma.
Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.
Guo H; Zhang R; Afrifa J; Wang Y; Yu J
Pathol Res Pract; 2019 Jun; 215(6):152403. PubMed ID: 30962003
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of FOS-like antigen 1 in gastric adenocarcinoma.
Zhu X; Liu H; Xu Z; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152394. PubMed ID: 30935763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
